MedPath

A prospective open-randomized controlled trial comparing postoperative chemoradiotherapy versus chemotherapy for cervical cancer patients with lymph node metastases.

Phase 2
Conditions
Patients who had radical hysterectomy for stage IB-IIB cervical cancer, and were certified to have lymph node mestastases histologocally after radical surgery. Patients with only squamous cell carcinoma were eligible.
Registration Number
JPRN-C000000076
Lead Sponsor
Study Group of Postoperative radiotherapy for cervical cancer.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
170
Inclusion Criteria

Not provided

Exclusion Criteria

1. Past history of pelvic surgery (except appendectomy). 2. past history of pelvic irradiation. 3. Positive surgical margin, or positive paraaortic lymph nodes. 4. Estimaated survival is less than 6 months. 5. Renal dysfunction. 6. Acitve infection (Tuberculosis or mycosis) in the pelvis. 7. Active double cancer. 8. Otehr reasons that is not eligible to this trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrent rata including distant metastases.
Secondary Outcome Measures
NameTimeMethod
ate adverse effect Survival
© Copyright 2025. All Rights Reserved by MedPath